FDA authorizes new e-cigarettes amid political backlash and youth-vaping concerns

The Food and Drug Administration completed a 615-day review of new e-cigarette products and issued marketing authorizations, highlighting that 20%-35% of adult smokers using tobacco-flavored pods and roughly 28%-50% of menthol-pod users stopped smoking after six weeks. The agency applied the public-health standard set by the 2009 Family Smoking Prevention and Tobacco Control Act, weighing adult cessation benefits against potential new nicotine uptake.

While the FDA did not label the devices as cessation tools, it concluded they meet the statutory criteria for market approval. Lawmakers such as Rep. Raja Krishnamoorthi condemned the decision, calling for stricter action on youth vaping, yet provided no counter-analysis to the agency’s data. Youth vaping prevalence fell to 5.2% in 2025, a record low, supporting the agency’s stance.

The piece notes that most of the 6,000+ e-cigarette products on the market are unauthorized, with the Justice Department taking limited enforcement actions, underscoring the need for a faster legal review pathway. The author urges policymakers to recognize the evidence-based approval while remaining vigilant about youth use.